Overview
Yongliang Ma practices practicing medicine in Beijing, China.
Their clinical expertise encompasses Familial Prostate Cancer, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), and Prostate Cancer.
They are actively involved in clinical research, co-authoring 38 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yongliang Ma
Is Yongliang Ma a top-rated expert for Familial Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Yongliang Ma is classified as an Experienced expert for Familial Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yongliang Ma participate in research or clinical trials?
Yes. Yongliang Ma has published 38 articles and abstracts on conditions like Familial Prostate Cancer. You can view a list of Yongliang Ma's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Chromophobe Renal Cell Carcinoma
- Familial Prostate Cancer
- Prostate CancerMa isExperienced. Learn about Prostate Cancer.
- Renal Cell Carcinoma (RCC)